1. Home
  2. BDTX vs BFAC Comparison

BDTX vs BFAC Comparison

Compare BDTX & BFAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • BFAC
  • Stock Information
  • Founded
  • BDTX 2014
  • BFAC 2021
  • Country
  • BDTX United States
  • BFAC United States
  • Employees
  • BDTX N/A
  • BFAC N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • BFAC Blank Checks
  • Sector
  • BDTX Health Care
  • BFAC Finance
  • Exchange
  • BDTX Nasdaq
  • BFAC Nasdaq
  • Market Cap
  • BDTX 161.6M
  • BFAC 152.7M
  • IPO Year
  • BDTX 2020
  • BFAC 2021
  • Fundamental
  • Price
  • BDTX $2.62
  • BFAC $11.12
  • Analyst Decision
  • BDTX Strong Buy
  • BFAC
  • Analyst Count
  • BDTX 4
  • BFAC 0
  • Target Price
  • BDTX $15.50
  • BFAC N/A
  • AVG Volume (30 Days)
  • BDTX 591.8K
  • BFAC 4.9K
  • Earning Date
  • BDTX 11-05-2024
  • BFAC 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • BFAC N/A
  • EPS Growth
  • BDTX N/A
  • BFAC 140.63
  • EPS
  • BDTX N/A
  • BFAC 0.60
  • Revenue
  • BDTX N/A
  • BFAC N/A
  • Revenue This Year
  • BDTX N/A
  • BFAC N/A
  • Revenue Next Year
  • BDTX N/A
  • BFAC N/A
  • P/E Ratio
  • BDTX N/A
  • BFAC $18.56
  • Revenue Growth
  • BDTX N/A
  • BFAC N/A
  • 52 Week Low
  • BDTX $2.09
  • BFAC $10.78
  • 52 Week High
  • BDTX $7.66
  • BFAC $11.55
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 31.71
  • BFAC 52.05
  • Support Level
  • BDTX $3.16
  • BFAC $11.13
  • Resistance Level
  • BDTX $3.44
  • BFAC $11.14
  • Average True Range (ATR)
  • BDTX 0.22
  • BFAC 0.00
  • MACD
  • BDTX 0.03
  • BFAC -0.01
  • Stochastic Oscillator
  • BDTX 0.61
  • BFAC 62.50

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About BFAC Battery Future Acquisition Corp.

Battery Future Acquisition Corp is a blank check company.

Share on Social Networks: